BioNTech says Sobi's Oelkers will replace Sahin as its CEO
03/08/2026 10:09
BioNTech says Sobi's Oelkers will replace Sahin as its CEO Aug 3 (Reuters) - BioNTech 22UAy.DE said on Monday that Sobi's SOBIV.ST CEO Guido Oelkers will succeed Ugur Sahin as its chief executive from February 1, 2027 at latest.
(Reporting by Linda Pasquini, Editing by Ludwig Burger)
((linda.pasquini@thomsonreuters.com; +48 58 7785261;))
Recent news on Swedish Orphan Biovitrum AB (publ)
See all newsTop of the Street: SOBI, Sonova, BAT, Imperial Brands
SOBI slips after Ionis lowers Tryngolza sales forecast
Brief: Swedish Orphan Biovitrum Executive Sells, Buys Shares
Europe Research Roundup: Centrica, Fuchs, URW
Brief: Swedish Orphan Biovitrum Proposes Börje Ekholm As New Chair And Board Member At 2027 AGM